PortalPublikationenGlycine and the ketamine model of schizophrenia: Modulating ...

Glycine and the ketamine model of schizophrenia: Modulating the N-methyl-D-aspartate receptor (NMDAR) offers new insights into the glutamate hypothesis of schizophrenia

Standard

Glycine and the ketamine model of schizophrenia: Modulating the N-methyl-D-aspartate receptor (NMDAR) offers new insights into the glutamate hypothesis of schizophrenia. / Haaf, Moritz; Curic, Stjepan; Steinmann, Saskia; Rauh, Jonas; Mulert, Christoph; Leicht, Gregor.

in: PHARMACOPSYCHIATRY, Jahrgang 55, Nr. 06, 312, 08.11.2022.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Konferenz-Abstract in Fachzeitschrift › Forschung › Begutachtung

Harvard

Haaf, M, Curic, S, Steinmann, S, Rauh, J, Mulert, C & Leicht, G 2022, 'Glycine and the ketamine model of schizophrenia: Modulating the N-methyl-D-aspartate receptor (NMDAR) offers new insights into the glutamate hypothesis of schizophrenia', PHARMACOPSYCHIATRY, Jg. 55, Nr. 06, 312. https://doi.org/10.1055/s-0042-1757664

APA

Haaf, M., Curic, S., Steinmann, S., Rauh, J., Mulert, C., & Leicht, G. (2022). Glycine and the ketamine model of schizophrenia: Modulating the N-methyl-D-aspartate receptor (NMDAR) offers new insights into the glutamate hypothesis of schizophrenia. PHARMACOPSYCHIATRY, 55(06), [312]. https://doi.org/10.1055/s-0042-1757664

Vancouver

Haaf M, Curic S, Steinmann S, Rauh J, Mulert C, Leicht G. Glycine and the ketamine model of schizophrenia: Modulating the N-methyl-D-aspartate receptor (NMDAR) offers new insights into the glutamate hypothesis of schizophrenia. PHARMACOPSYCHIATRY. 2022 Nov 8;55(06). 312. https://doi.org/10.1055/s-0042-1757664

Bibtex

@article{5dbf5fbd28d24a0ea98ac47abda1cc11,
title = "Glycine and the ketamine model of schizophrenia: Modulating the N-methyl-D-aspartate receptor (NMDAR) offers new insights into the glutamate hypothesis of schizophrenia",
author = "Moritz Haaf and Stjepan Curic and Saskia Steinmann and Jonas Rauh and Christoph Mulert and Gregor Leicht",
year = "2022",
month = nov,
day = "8",
doi = "10.1055/s-0042-1757664",
language = "English",
volume = "55",
journal = "PHARMACOPSYCHIATRY",
issn = "0176-3679",
publisher = "Georg Thieme Verlag KG",
number = "06",

}

RIS

TY - JOUR

T1 - Glycine and the ketamine model of schizophrenia: Modulating the N-methyl-D-aspartate receptor (NMDAR) offers new insights into the glutamate hypothesis of schizophrenia

AU - Haaf, Moritz

AU - Curic, Stjepan

AU - Steinmann, Saskia

AU - Rauh, Jonas

AU - Mulert, Christoph

AU - Leicht, Gregor

PY - 2022/11/8

Y1 - 2022/11/8

U2 - 10.1055/s-0042-1757664

DO - 10.1055/s-0042-1757664

M3 - Conference abstract in journal

VL - 55

JO - PHARMACOPSYCHIATRY

JF - PHARMACOPSYCHIATRY

SN - 0176-3679

IS - 06

M1 - 312

ER -